Market Tracker

07/31 6:45pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

8.20
Delayed Data
As of 3:59pm ET
 -0.06 / -0.73%
Today’s Change
6.13
Today|||52-Week Range
25.60
-48.88%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close8.26
Today’s open8.20
Day’s range8.07 - 8.51
Volume489,963
Average volume (3 months)725,107
Market cap$420.9M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+14.99%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.01+0.11%
LIFEaTyr Pharma Inc+0.61+3.36%
ANTHAnthera Pharmaceutic...+0.40+3.81%
TBPHTheravance Biopharma...+0.49+4.07%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
CFO, Secretary, CAO &
General Counsel
David L. Szekeres
Corporate headquarters
San Diego, California

Forecasts